Jpmorgan Chase & Co »

Blueprint Medicines shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $140M 1.5M 92.24
2023-09-30 $85M 1.7M 50.22
2023-06-30 $102M 1.6M 63.20
2023-03-31 $69M 1.5M 46.74
2022-12-31 $63M 1.4M 43.81
2022-06-30 $87M 1.7M 50.51
2022-03-31 $107M 1.7M 63.88
2021-12-31 $176M 1.6M 107.11
2021-03-31 $150M 1.5M 97.23
2020-12-31 $169M 1.5M 112.31
2020-09-30 $125M 1.4M 91.19
2020-06-30 $87M 1.1M 78.00
2020-03-31 $57M 970k 58.47
2019-12-31 $9.1M 114k 80.11
2019-09-30 $8.9M 122k 73.47
2019-06-30 $11M 113k 92.94
2019-03-31 $8.9M 111k 80.04
2018-12-31 $4.3M 79k 53.92
2018-09-30 $6.0M 77k 78.07
2018-06-30 $4.6M 73k 63.47
2018-03-31 $4.8M 53k 91.70
2017-12-31 $1.6M 21k 75.40
2017-06-30 $541k 11k 51.21
2017-03-31 $5.8M 145k 40.00
2016-12-31 $4.7M 167k 28.02
2016-09-30 $4.9M 165k 29.69
2016-06-30 $3.2M 159k 20.25
2016-03-31 $1.4M 80k 18.04
2015-12-31 $2.1M 79k 26.35
2015-09-30 $2.0M 92k 21.34
2015-06-30 $6.9M 262k 26.53